Patient info Search Menu

Water for Injections, PhEur, 100% w/v – Summary of Product Characteristics (SmPC) for healthcare professionals

Updated:
Medicine strength:
100% w/v

Summary of Product Characteristics (SmPC) - Water for Injections Pheur 100% w/v

1. NAME OF THE MEDICINAL PRODUCT

Water for Injections, PhEur, 100% w/v.

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Water for Injections PhEur, 100% w/v for reconstitution of vaccines

3. PHARMACEUTICAL FORM

Diluent containing sterile solution for the reconstitution of lyophilised vaccine preparations.

4 CLINICAL PARTICULARS

4.1 Therapeutic Indications

For reconstitution of freeze-dried vaccines.

4.2 Posology and Method of administration

As for product to be reconstituted

Route of Administration:

Subcutaneous or intramuscular injection.

4.3 Contra-Indications

As for product to be reconstituted.

4.4 Special Warnings and Special Precautions For Use

As for product to be reconstituted.

4.5 Interactions with other Medicinal Products and other Forms of Interaction

As for product to be reconstituted.

4.6 Pregnancy and Lactation

As for product to be reconstituted.

4.7 Effects on Ability to Drive and Use Machines

As for product to be reconstituted.

4.8 Undesirable Effects

As for product to be reconstituted.

4.9 Overdose

As for product to be reconstituted.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic Properties

Not applicable.

5.2 Pharmacokinetic Properties

Not applicable.

5.3 Preclinical Safety Data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of Excipients

None.

6.2 Incompatibilities

As for product to be reconstituted.

6.3 Shelf Life

24 months.

After reconstitution: 1 Hour.

6.4 Special Precautions for Storage

Protect from light, store between 2 - 8°C. Do not freeze.

6.5 Nature and Contents of Container

Type I, Ph Eur glass syringes with stainless steel needle fitted with rubber needle shields and stoppers. The stoppers are attached to a polypropylene or polystyrene plunger.

Type I, Ph Eur clear glass vials with rubber closures and Aluminium overcaps.

Type I, Ph Eur clear glass ampoules (self-sealed, breakable).

Type I, PhEur glass needleless syringe fitted with a rubber tip cap and backstop device. The stoppers are attached to polypropylene or polystyrene plunger.

A separate needle fitted with needle shield may be supplied in the carton.

6.6 Instructions for Use/Handling

None

7 MARKETING AUTHORISATION HOLDER

SmithKline Beecham Limited

980 Great West Road, Brentford,

Middlesex TW8 9GS

Trading as

GlaxoSmithKline UK

8. MARKETING AUTHORISATION NUMBER(S)

PL 10592/0021

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

22nd September 1998

10 DATE OF REVISION OF THE TEXT

02/07/2020

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 10592/0021

Last revision stated in the text: 2 July 2020 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Water for Injections Pheur 100% w/v

What these facts mean

Strength? 100% w/v
Excipients? None.
Shelf life? 24 months.
After reconstitution: 1 Hour.
Storage Protect from light, store between 2 - 8°C. Do not freeze.
Marketing authorisation? PL 10592/0021 (first authorised 22 September 1998)
Marketing authorisation holder? SmithKline Beecham Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.